AstraZeneca

London: The World Health Organization (WHO) on Friday jumped to AstraZeneca's defence saying there is no reason to stop using the vaccine. Earlier, Denmark, followed by ten other European…

London: The Oxford-AstraZeneca vaccine, whose Indian version is  Covishield, is going through a rough phase. After 8 European nations temporarily suspended the vaccine due to possible blood…

Seoul/New Delhi: Soon after receiving the AstraZeneca vaccine against COVID-19, a patient, with underlying diseases, in a long-term care hospital in South Korea died on Wednesday. The…

For the first time, the University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children, it said…

Geneva: The World Health Organization and its Covax partners have cautioned against dismissing AstraZeneca’s COVID-19 vaccine after several setbacks, insisting it remained an important,…

New Delhi: The COVID-19 vaccine developed by Oxford University and AstraZeneca give good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford’s…

New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield,…

Mumbai: The Oxford-AstraZeneca vaccine being made at the Serum Institute in Pune will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna vaccines", Pascal…

Mumbai: The COVID-19 vaccine, co-developed by the University of Oxford and drug manufacturer AstraZeneca, is likely to get emergency use approval first in India, a report has claimed.…

London: British pharma giant AstraZeneca is contemplating combining its COVID-19 vaccine with Russian Sputnik V vaccine in a bid to increase efficacy. AstraZeneca said on Friday it will…